Treatment of thyrotoxicosis with radioiodine (аnalytical review of literature and own clinical data)

Background. Thyrotoxicosis syndrome is a severe disease of the thyroid that adversely affects functioning of almost all organs and body systems and can result in serious complications like ciliary arrhythmia, cardiovascular inefficiency, thyroid eye disease with visual deterioration, multi-organ fai...

Full description

Bibliographic Details
Main Author: Н. І. Луховицька
Format: Article
Language:English
Published: National Academy of Medical Sciences of Ukraine. Grigoriev Institute for Medical Radiology and Oncology 2020-09-01
Series:Український радіологічний та онкологічний журнал
Subjects:
Online Access:https://ukroj.com/index.php/journal/article/view/43
_version_ 1819101368925814784
author Н. І. Луховицька
author_facet Н. І. Луховицька
author_sort Н. І. Луховицька
collection DOAJ
description Background. Thyrotoxicosis syndrome is a severe disease of the thyroid that adversely affects functioning of almost all organs and body systems and can result in serious complications like ciliary arrhythmia, cardiovascular inefficiency, thyroid eye disease with visual deterioration, multi-organ failure. The choice of treatment strategy, its sequence and radioiodine therapy effectiveness in thyrotoxicosis and other non-oncological diseases of the thyroid gland is still a challenging issue in endocrinology and radiology. Purpose. To analyze the literature data regarding radionuclide treatment in patients with thyrotoxicosis and to present own experience-outcomes of radioiodine treatment administered to 146 patients with thyrotoxicosis symptoms and 9 patients with other non-oncological thyroid pathology at SO «Grigoriev Institute for Medical Radiology and Oncology» during 2010–2019. Materials and methods. The literature analysis involved 34 sources of information in the form of scientific articles, research papers, monographies, etc. Among them, 4 sources were domestic, 3 sources were Russian, the other 27 were taken from the foreign scientific journals. The evidence level of researching varies from І А to ІІІ С. The analysis of own findings has been carried out for the period from 2010 to the first half of 2020. Treatment with 131I-sodium iodide was provided in liquid or capsule form, per os; 155 patients in total underewnt treatment. Radioiodine activity per a course ranged from 185 MBq to 1110 MBq, the number of courses was chosen individually. Results and discussion. The analytical review of modern domestic and foreign literature has made it possible to define that radioiodine treatment still plays an important role in treatment of thyrotoxicosis, especially for patients with recurrent and resistant to thyrostatics disease form. Our own data showed that the treatment was reasonable to be administered via high radioiodine doses (600–1000 MBq), that resulted in curing the disease in 98 % (113 patients with Graves’ disease and 33 patients with toxic multinodular goiter). The effectiveness of radioiodine therapy for patients with AIT (2 cases) and in case of the retrosternal location of the thyroid gland (7 patients) has been proven. Conclusions. Radioiodine treatment remains a modern and effective way to overcome such conditions as Graves’ disease, TMNG (toxic multinodular goiter), retrosternal location of hyperplastic thyroid gland, AIT.
first_indexed 2024-12-22T01:17:34Z
format Article
id doaj.art-2de05779fd064e2cbca93b39c4ea6650
institution Directory Open Access Journal
issn 2708-7166
2708-7174
language English
last_indexed 2024-12-22T01:17:34Z
publishDate 2020-09-01
publisher National Academy of Medical Sciences of Ukraine. Grigoriev Institute for Medical Radiology and Oncology
record_format Article
series Український радіологічний та онкологічний журнал
spelling doaj.art-2de05779fd064e2cbca93b39c4ea66502022-12-21T18:43:48ZengNational Academy of Medical Sciences of Ukraine. Grigoriev Institute for Medical Radiology and OncologyУкраїнський радіологічний та онкологічний журнал2708-71662708-71742020-09-0128324125410.46879/ukroj.3.2020.241-25443Treatment of thyrotoxicosis with radioiodine (аnalytical review of literature and own clinical data)Н. І. Луховицька0State Organization «Grigoriev Institute for Medical Radiology and Oncology of the National Academy of Medical Sciences of Ukraine», Kharkiv, UkraineBackground. Thyrotoxicosis syndrome is a severe disease of the thyroid that adversely affects functioning of almost all organs and body systems and can result in serious complications like ciliary arrhythmia, cardiovascular inefficiency, thyroid eye disease with visual deterioration, multi-organ failure. The choice of treatment strategy, its sequence and radioiodine therapy effectiveness in thyrotoxicosis and other non-oncological diseases of the thyroid gland is still a challenging issue in endocrinology and radiology. Purpose. To analyze the literature data regarding radionuclide treatment in patients with thyrotoxicosis and to present own experience-outcomes of radioiodine treatment administered to 146 patients with thyrotoxicosis symptoms and 9 patients with other non-oncological thyroid pathology at SO «Grigoriev Institute for Medical Radiology and Oncology» during 2010–2019. Materials and methods. The literature analysis involved 34 sources of information in the form of scientific articles, research papers, monographies, etc. Among them, 4 sources were domestic, 3 sources were Russian, the other 27 were taken from the foreign scientific journals. The evidence level of researching varies from І А to ІІІ С. The analysis of own findings has been carried out for the period from 2010 to the first half of 2020. Treatment with 131I-sodium iodide was provided in liquid or capsule form, per os; 155 patients in total underewnt treatment. Radioiodine activity per a course ranged from 185 MBq to 1110 MBq, the number of courses was chosen individually. Results and discussion. The analytical review of modern domestic and foreign literature has made it possible to define that radioiodine treatment still plays an important role in treatment of thyrotoxicosis, especially for patients with recurrent and resistant to thyrostatics disease form. Our own data showed that the treatment was reasonable to be administered via high radioiodine doses (600–1000 MBq), that resulted in curing the disease in 98 % (113 patients with Graves’ disease and 33 patients with toxic multinodular goiter). The effectiveness of radioiodine therapy for patients with AIT (2 cases) and in case of the retrosternal location of the thyroid gland (7 patients) has been proven. Conclusions. Radioiodine treatment remains a modern and effective way to overcome such conditions as Graves’ disease, TMNG (toxic multinodular goiter), retrosternal location of hyperplastic thyroid gland, AIT.https://ukroj.com/index.php/journal/article/view/43radioiodine treatment, graves’ disease, toxic multinodular goiter, autoimmune thyroiditis.
spellingShingle Н. І. Луховицька
Treatment of thyrotoxicosis with radioiodine (аnalytical review of literature and own clinical data)
Український радіологічний та онкологічний журнал
radioiodine treatment, graves’ disease, toxic multinodular goiter, autoimmune thyroiditis.
title Treatment of thyrotoxicosis with radioiodine (аnalytical review of literature and own clinical data)
title_full Treatment of thyrotoxicosis with radioiodine (аnalytical review of literature and own clinical data)
title_fullStr Treatment of thyrotoxicosis with radioiodine (аnalytical review of literature and own clinical data)
title_full_unstemmed Treatment of thyrotoxicosis with radioiodine (аnalytical review of literature and own clinical data)
title_short Treatment of thyrotoxicosis with radioiodine (аnalytical review of literature and own clinical data)
title_sort treatment of thyrotoxicosis with radioiodine аnalytical review of literature and own clinical data
topic radioiodine treatment, graves’ disease, toxic multinodular goiter, autoimmune thyroiditis.
url https://ukroj.com/index.php/journal/article/view/43
work_keys_str_mv AT níluhovicʹka treatmentofthyrotoxicosiswithradioiodineanalyticalreviewofliteratureandownclinicaldata